Global Regenerative Medicine Market Forecasts to 2019: Research Segmented on Orthopedics, Skin/Integumentary, Cardiology, Neurology, and Urology
(PRWEB) May 13, 2015 -- Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017, growing at a CAGR of 12.2% for the analysis period 2013-2019 respectively. Skin/Integumentary and Urology together account for approximately 25.97% (2016) of the market are expected to support the Regenerative Medicine Industry going forward. Geographical analysis for Regenerative Medicine in Cardiology shows that the highest Compounded Annual Growth Rate (CAGR) of 18.1% is anticipated from Asia-Pacific region during the analysis period 2013-2019. Browse list of table and charts of ‘Global Regenerative Medicine Market’ report @ http://www.rnrmarketresearch.com/regenerative-medicine-global-trends-estimates-and-forecasts-2013-2019-market-report.html .
The report ‘Regenerative Medicine – Global Trends, Estimates and Forecasts, 2013-2019’ reviews the latest trends in regenerative medicine with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.
Companies profiled in regenerative medicine market research report are Cell2b, Angiocrine Bioscience, Platelet Biogenesis, Biomatrica, Inc, Athersys, Inc., Cellular Dynamics International, Inc., Tengion Inc, Vericel Corporation, Wright Medical Technology, Tissuegene, Inc., Shire Regenerative Medicine, Regen Biopharma (Bio-Matrix Scientific Group), DSSM Biomedical, Harvard Apparatus Regenerative Technology, Cellserve GMBH, Trakcel Ltd, Crispr Therapeutics, Cytori Therapeutics Inc, Cyfuse Biomedical KK, Regenovo Biotechnology, and Cynata Therapeutics Limited. Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=368914 .
The period considered for the regenerative medicine market analysis is 2013-2019. The region wise distribution of the market consists of The Americas (USA, Brazil, Canada and Rest of The Americas), Europe (Germany, United Kingdom, France, Switzerland, Spain, The Netherlands,Russia and Rest of Europe), Asia-Pacific (Japan, South Korea, Australia, China, India and Rest of Asia-Pacific) and Rest of World (Africa and Middle East).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.
More than 600 market players are identified in regenerative medicine industry out of which 21 key companies that project improved market activities in the near future are profiled. The report consists of 99 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Priced at $4710 for a single user PDF, a discount on “Regenerative Medicine – Global Trends, Estimates and Forecasts, 2013-2019” research report can be requested at http://www.rnrmarketresearch.com/contacts/discount?rname=368914 .
Related Market Reports:
"Orthopedics (Devices & Materials) – Global Trends, Estimates and Forecasts, 2013-2019” is an Apr 2015 publication of 472 pages and it says global orthopedics (Devices and Material) market is estimated to reach US$57.2 billion by 2017. Devices types; Joints (Repair & Replacement) Industry market is worth US$40.2 billion by 2017, growing at a CAGR of 8.9% for the analysis period 2013-2019 respectively. The Americas region accounts for highest percentage approximately 56.6% (2016) of global share while Europe follows next with nearly 19.7% (2019) of the market. Companies profiled in this research report are Aesculap, Inc., Amedica Corp., Arthrocare Corporation, Biomet, Inc., Conmed Corp, Corin Group Plc,
Depuy Synthess, Inc., Donjoy, Inc., Exactech, Inc., Globus Medical, Inc., In'tech Medical Sas, Integra Lifesciences Holding Corporation, Medtronic, Inc., Pro Orthopedic Devices, Inc., Smith & Nephew Plc, Stryker Corporation, Wright Medical Technology, Inc., Zimmer, Inc., and many more companies from Europe, Asia-Pacific, and RoW. Complete research available at http://www.rnrmarketresearch.com/orthopedics-devices-materials-global-trends-estimates-and-forecasts-2013-2019-market-report.html .
"Hemodynamic Monitoring Devices – Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018” is a Nov 2014 publication of 480 pages and it says BRICSS Hemodynamic Monitoring Devices market value is expected to reach US$281 million by 2016, primarily supported by the product types – Cardiac Output Monitoring Devices and Pulmonary Artery Catheters. China accounts for nearly 24% of the market share and India claims more than 24%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Complete research available at http://www.rnrmarketresearch.com/hemodynamic-monitoring-devices-emerging-markets-brazil-russia-india-china-south-africa-and-south-korea-2012-2018-market-report.html .
Explore more Life Sciences Market Research Reports at http://www.rnrmarketresearch.com/reports/life-sciences .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
Ritesh Tiwari, RnRMarketResearch.com, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article